Cronos Group Inc (CRON)

[venswam]

As ACB was crushed, it is only natural that it had a recovery like the one we have seen. Cronos has not had that recovery because the market continues to look at production capacity and capitalization beyond any other factor, and Cronos continues to be seen as a traditional cannabis company. The only thing that will turn investors' heads is the growth in sales and the reduction in spending, beyond any other news of progress in technologies or trade agreements. In my opinion this will continue to range between $ 4 and $ 6 until this step is achieved.